Parving H H, Rutili F, Granath K, Noer I, Deckert T, Lyngsøe J, Lassen N A
Diabetologia. 1979 Sep;17(3):157-60. doi: 10.1007/BF01219742.
Renal clearance of dextran of two ranges of molecular size and glomerular filtration rate (GFR, 51Cr-EDTA) were measured in seven short-term insulin-dependent diabetics (mean age 25 years). Measurements were carried out in the same patient during good and poor metabolic regulation (plasma glucose, mean +/- SEM, 6.5 +/- 0.9 and 14.8 +/- 1.5 mmol/l, respectively). GFR was elevated in all patients during poor metabolic regulation (119 +/- 6 ml/min/1.73 m2, versus 99 +/- 2 ml/min/1.73 m2 during good control, p less than 0.01). The average renal clearance of dextran with molecular weights ranging from 25,000 to 35,000 and 35,000 to 45,000 increased during poor metabolic regulation from 14.8 +/- 0.8 to 19.8 +/- 1.8 ml/min/1.73 m2, and 5.2 +/- 0.3 to 6.8 +/- 0.6 ml/min/1.73 m2, respectively (p less than 0.05). The elevated GFR and renal dextran clearance found during poor metabolic regulation were normalized within one to three weeks of effective insulin treatment. This rapid reversibility can hardly be explained by the previously demonstrated enlargement in glomerular size and filtration surface area, since these alterations remain unchanged after more than one month of insulin treatment. The metabolic regulation did not influence the size-selective properties of the glomerular wall. Therefore, we suggest that the dominating mechanism involved in the GFR and renal dextran clearance alterations is functional, viz. increased filtration pressure.
在7名短期胰岛素依赖型糖尿病患者(平均年龄25岁)中,测量了两种分子大小范围的右旋糖酐的肾清除率以及肾小球滤过率(GFR,用51Cr-EDTA测定)。在代谢调控良好和不佳的同一患者身上进行了测量(血浆葡萄糖,平均值±标准误,分别为6.5±0.9和14.8±1.5 mmol/L)。在代谢调控不佳期间,所有患者的GFR均升高(119±6 ml/min/1.73 m2,而良好控制时为99±2 ml/min/1.73 m2,p<0.01)。分子量在25,000至35,000以及35,000至45,000之间的右旋糖酐的平均肾清除率在代谢调控不佳期间分别从14.8±0.8增至19.8±1.8 ml/min/1.73 m2以及从5.2±0.3增至6.8±0.6 ml/min/1.73 m2(p<0.05)。在代谢调控不佳期间发现的升高的GFR和肾右旋糖酐清除率在有效胰岛素治疗1至3周内恢复正常。这种快速可逆性很难用先前证明的肾小球大小和滤过表面积增大来解释,因为在胰岛素治疗超过1个月后这些改变仍未改变。代谢调控并未影响肾小球壁的大小选择性特性。因此,我们认为参与GFR和肾右旋糖酐清除率改变的主要机制是功能性的,即滤过压力增加。